(Q46902620)

26 December 2017

title

Chemical hypoxia facilitates alternative splicing of EAAT2 in presymptomatic APP23 transgenic mice (English)

1 reference

26 December 2017

alternative mRNA splicing, via spliceosome

1 reference

1 reference

6

Albert C Ludolph

1 reference

26 December 2017

Christoph Münch

1

1 reference

26 December 2017

Bing-gen Zhu

2

1 reference

26 December 2017

Andreas Mink

3

1 reference

26 December 2017

Ulrich Seefried

4

1 reference

26 December 2017

Matthias W Riepe

5

1 reference

26 December 2017

Thomas Meyer

7

1 reference

26 December 2017

publication date

13 November 2007

1 reference

26 December 2017

published in

Neurochemical Research

1 reference

26 December 2017

volume

33

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

1005-1010

1 reference

26 December 2017

Delayed poststroke dementia: a 4-year follow-up study.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9540-5

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9540-5

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9540-5

Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-007-9540-5

Silent brain infarcts and the risk of dementia and cognitive decline

21 January 2018

1 reference

12 December 2020

Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists

1 reference

12 December 2020

Altered expression of the glutamate transporter EAAT2b in neurological disease

1 reference

12 December 2020

Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis

1 reference

12 December 2020

Regulation of glutamate transporters in health and disease

1 reference

12 December 2020

The 5' UTR of protein kinase C epsilon confers translational regulation in vitro and in vivo

1 reference

12 December 2020

Loss of glial glutamate transporters and induction of neuronal expression of GLT-1B in the hypoxic neonatal pig brain

1 reference

12 December 2020

Alternative splicing of glutamate transporter EAAT2 RNA in neocortex and hippocampus of temporal lobe epilepsy patients

1 reference

12 December 2020

Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study

1 reference

12 December 2020

Transgenic mouse models of Alzheimer's disease

1 reference

12 December 2020

ATP Deficits and Neuronal Degeneration Induced by 3-Nitropropionic Acid

1 reference

12 December 2020

Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-κB

1 reference

12 December 2020

Impaired RNA splicing of 5'-regulatory sequences of the astroglial glutamate transporter EAAT2 in human astrocytoma

1 reference

12 December 2020

Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid

1 reference

12 December 2020

Multiple 5'-splice variants of the rat glutamate transporter-1.

1 reference

12 December 2020

Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization

1 reference

12 December 2020

Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration

1 reference

12 December 2020

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

Differential RNA cleavage and polyadenylation of the glutamate transporter EAAT2 in the human brain

1 reference

12 December 2020

A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease.

1 reference

12 December 2020

Relation of cerebral infarctions to dementia and cognitive function in older persons

1 reference

12 December 2020

Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury

1 reference

12 December 2020

Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice

1 reference

12 December 2020

Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection.

1 reference

12 December 2020

Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.

1 reference

12 December 2020

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

1 reference

12 December 2020

10.1007/S11064-007-9540-5

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017